share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Hoch Lynelle

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  03/12 20:04
Moomoo AI 已提取核心訊息
On March 10, 2024, Lynelle Hoch, President of Cell Therapy Org. at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Hoch acquired a total of 4,351 shares through the exercise of derivative securities at no cost. On the same day, Hoch disposed of 2,625 shares through various transactions, including the payment of exercise price or tax liability by delivering or withholding securities, with some shares sold at a price of $53.79 each. The total market value of the disposed shares amounted to $70,357.32. After these transactions, Hoch's direct holdings in Bristol-Myers Squibb common stock amounted to 1,726 shares.
On March 10, 2024, Lynelle Hoch, President of Cell Therapy Org. at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Hoch acquired a total of 4,351 shares through the exercise of derivative securities at no cost. On the same day, Hoch disposed of 2,625 shares through various transactions, including the payment of exercise price or tax liability by delivering or withholding securities, with some shares sold at a price of $53.79 each. The total market value of the disposed shares amounted to $70,357.32. After these transactions, Hoch's direct holdings in Bristol-Myers Squibb common stock amounted to 1,726 shares.
2024年3月10日，百時美施貴寶（BMY）細胞療法組織總裁萊內爾·霍赫完成了一系列涉及該公司普通股的交易。霍赫通過免費行使衍生證券，共收購了4,351股股票。同一天，霍赫通過各種交易出售了2625股股票，包括通過交付或預扣證券來支付行使價或納稅義務，其中一些股票以每股53.79美元的價格出售。已處置股份的總市值爲70,357.32美元。在這些交易之後，霍赫直接持有的百時美施貴寶普通股爲1,726股。
2024年3月10日，百時美施貴寶（BMY）細胞療法組織總裁萊內爾·霍赫完成了一系列涉及該公司普通股的交易。霍赫通過免費行使衍生證券，共收購了4,351股股票。同一天，霍赫通過各種交易出售了2625股股票，包括通過交付或預扣證券來支付行使價或納稅義務，其中一些股票以每股53.79美元的價格出售。已處置股份的總市值爲70,357.32美元。在這些交易之後，霍赫直接持有的百時美施貴寶普通股爲1,726股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息